Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Franco Vito Piantedosi
Observed names:
F Piantedosi,
F V Piantedosi,
F. Piantedosi,
F. V. Piantedosi,
F.V. Piantedosi
Institution:
Ospedale Monaldi
Observed institutions:
University of Campania "Luigi Vanvitelli",
Istituto Oncologico Veneto,
Azienda Ospedaliera S.Giuseppe Moscati,
Centro di Riferimento Oncologico,
Ospedale Monaldi,
National Cancer Institute,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Palermo
show all 8
OpenAlex ID:
A5038581704
Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
2003
·
C. Gridelli
, F. Perrone
, et al.
·
JNCI Journal of the National Cancer Institute
·
824
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
2005
·
Massimo Di Maio
, Cesare Gridelli
, et al.
·
The Lancet Oncology
·
252
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
2004
·
on behalf of the DISTAL (Docetaxel In Second-line Treatment of Advanced Lung cancer) Investigators
, C Gridelli
, et al.
·
British Journal of Cancer
·
167
PDF
Cisplatin Plus Gemcitabine or Vinorelbine for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The MILES-2P Studies
2007
·
Cesare Gridelli
, Paolo Maione
, et al.
·
Journal of Clinical Oncology
·
85
PDF
EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study
2011
·
Umberto Malapelle
, Nicla de Rosa
, et al.
·
Journal of Clinical Pathology
·
84
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients
2013
·
Umberto Malapelle
, Claudio Bellevicine
, et al.
·
Cancer Cytopathology
·
83
PDF
Treatment of pulmonary neuroendocrine tumours: State of the art and future developments
2012
·
Cesare Gridelli
, Antonio Rossi
, et al.
·
Cancer Treatment Reviews
·
72
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: Results of an Experts Panel Meeting
2007
·
C. Gridelli
, P. Maione
, et al.
·
Critical Reviews in Oncology/Hematology
·
50
EGFR mutations detection on liquid-based cytology: is microscopy still necessary?
2012
·
Umberto Malapelle
, Nicla de Rosa
, et al.
·
Journal of Clinical Pathology
·
39
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study
2001
·
G Frasci
, G Nicolella
, et al.
·
British Journal of Cancer
·
29
PDF
Supportive care in patients with advanced non-small-cell lung cancer
2003
·
M Di Maio
, F Perrone
, et al.
·
British Journal of Cancer
·
26
PDF
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy
2008
·
Marcello Tiseo
, Cesare Gridelli
, et al.
·
Lung Cancer
·
21
Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study
2007
·
F. V. Piantedosi
, F. Caputo
, et al.
·
Cancer Chemotherapy and Pharmacology
·
14
231 Gemcitabine (GEM)-cisplatin (CDDP)-vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC). A phase II randomized study
1997
·
P. Comella
, N. Panza
, et al.
·
Lung Cancer
·
7
P1.01-53 Bone Metastases and Efficacy of Immunotherapy in Patients with Pretreated Advanced Non-Small-Cell Lung Cancer (NSCLC)
2018
·
L. Landi
, F. D'Incà
, et al.
·
Journal of Thoracic Oncology
·
1
Gemcitabine (GEM) — Cisplatin (COOP) — Vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC). A phase II randomized study
1997
·
P. Comella
, N. Panza
, et al.
·
European Journal of Cancer
·
1
1048P Molecular predictors of immunotherapy efficacy in lung squamous-cell carcinoma (LSCC): Results from the randomized prospective SQUINT trial
2022
·
F. Cappuzzo
, A. Delmonte
, et al.
·
Annals of Oncology
PDF
P781 Role of serum biomarkers combined with two-dimensional speckle tracking echocardiography for screening of immunotherapy-induced cardiotoxicity
2020
·
F Fusco
, G Scognamiglio
, et al.
·
European Heart Journal - Cardiovascular Imaging
PDF
Nivolumab in patients with previously treated advanced NSCLC in clinical practice and correlation with immunological characteristics
2016
·
F. Vitiello
, B. Casale
, et al.
·
Annals of Oncology
Anemia management with epoetin beta in anemic patients with cancer receiving chemotherapy: Pananemia observational study on clinical practice.
2011
·
S. Del Prete
, F. Piantedosi
, et al.
·
Journal of Clinical Oncology
Two consecutive phase 1–2 studies of cisplatin (P)-based 1st-line chemotherapy (CT) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC). The MILES-2P studies
2006
·
F. Perrone
, A. Illiano
, et al.
·
Journal of Clinical Oncology
A randomized clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL (Docetaxel in Second-Line Treatment of Advanced Lung Cancer)
2004
·
Alfredo Falcone
, C. Gridelli C. Gallo
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
Show more works
View as search
Works count:
22
Citation count:
1,755
H-index:
13
I10-index:
13
Year
Topic
Type